Table 1.
Patient and tumor characteristics (n = 56)
| Characteristic | Level | % (n) |
|---|---|---|
| Age | Median (range) | 66 (47-81) |
| Age ≥ 70 | Yes | 32 (18) |
| Race | Caucasian African American Unknown/Other |
70 (39) 20 (11) 10 (6) |
| Obese (BMI ≥ 30) | Yes | 53 (29) |
| Smoking history | Yes | 22 (12) |
| Oral contraceptive history | Yes | 36 (19) |
| History of hormone replacement therapy | Yes | 6 (3) |
| Family history of cancer | Yes | 40 (22) |
| Histology | Mixed USC/Other Pure uterine serous carcinoma |
40 (22) 60 (34) |
| Endocervical glandular involvement | Yes | 16 (9) |
| Endocervical stromal involvement | Yes | 9 (5) |
| Myometrial invasion ≥ 50% | Yes | 21 (12) |
| Stage – FIGO 2009 | IA IB II |
73 (41) 18 (10) 9 (5) |
| Stage – FIGO 1988 | IA IB IC IIA IIB IIIA |
25 (13) 41 (22) 18 (10) 7 (4) 9 (5) 4 (2) |
| Lymph-vascular space invasion | Yes | 29 (16) |
| Lower uterine segment involvement | Yes | 38 (20) |
| Cytology positive | Yes | 4 (2) |